Hendershot Investments’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Hendershot Investments’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-17,662	Closed	-$952K	–	71
2017 Q4	$952K	Buy	17,662 +807	+5%	+$44.2K	0.38%	45
2017 Q3	$962K	Buy	16,855 +6,893	+69%	+$404K	0.41%	47
2017 Q2	$599K	Buy	9,962 +280	+3%	+$15.9K	0.27%	47
2017 Q1	$527K	Buy	+9,682	New	+$477K	0.24%	51

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Hendershot Investments's BIVV Position: Q1 2018 in Review

Hendershot Investments sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 17,662 shares — an estimated $952K sold.

Hendershot Investments first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $962K in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Hendershot Investments reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Hendershot Investments sold 17,662 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $952K.
Hendershot Investments first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Hendershot Investments's Bioverativ Inc. Common Stock position peaked at $962K in Q3 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Hendershot Investments's 13F filing for Q1 2018, filed 17 Apr 2018.